GLISAXAPIN M 2.5/500:Uses, Dosage, Side Effects, Price, Composition and Mechanism of Action

GLISAXAPIN M 2.5/500

Saxagliptin (2.5mg), Metformin HCI (ER) (500mg)

GLISAXAPIN M 2.5/500 combines Saxagliptin (2.5mg) and Metformin HCI (ER) (500mg) to provide an effective treatment option for individuals with type 2 diabetes mellitus. This article explores the synergistic benefits, therapeutic uses, potential side effects, and considerations associated with GLISAXAPIN M 2.5/500 therapy.

Understanding GLISAXAPIN M 2.5/500:

• Saxagliptin (2.5mg): Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that improves glycemic control by increasing insulin secretion and decreasing glucagon levels in a glucose-dependent manner.

• Metformin HCI (ER) (500mg): Metformin is a biguanide antidiabetic agent that reduces hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity.

Benefits of GLISAXAPIN M 2.5/500:

• Dual Mechanism of Action: GLISAXAPIN M 2.5/500 combines the complementary mechanisms of Saxagliptin and Metformin HCI to effectively lower blood glucose levels.

• Improved Glycemic Control: By enhancing insulin secretion and reducing insulin resistance, GLISAXAPIN M 2.5/500 helps achieve and maintain optimal glycemic control in patients with type 2 diabetes mellitus.

Therapeutic Uses:

• Combination Therapy: It can be used as monotherapy or in combination with other antidiabetic medications to achieve target blood glucose levels.

Considerations for Use:

• Dosage Adjustment: The dosage of GLISAXAPIN M 2.5/500 may require adjustment based on renal function. Regular monitoring of renal function is recommended during therapy.

• Adherence to Treatment Plan: Patients should adhere to the prescribed dosage and administration schedule to maximize the benefits of GLISAXAPIN M 2.5/500 and minimize the risk of adverse effects.

Potential Side Effects:

• Gastrointestinal Disturbances: Common side effects of GLISAXAPIN M 2.5/500 may include nausea, vomiting, diarrhea, and abdominal discomfort. These effects are usually transient and can be minimized by taking the medication with meals.

Conclusion:

GLISAXAPIN M 2.5/500 offers a valuable combination of Saxagliptin (2.5mg) and Metformin HCI (ER) (500mg), providing synergistic benefits for individuals with type 2 diabetes mellitus. By understanding its mechanism of action, therapeutic uses, and considerations for use, healthcare providers can optimize the use of GLISAXAPIN M 2.5/500 to improve glycemic control and enhance patient outcomes.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW